bioRxiv preprint doi: https://doi.org/10.1101/2020.01.07.897199; this version posted January 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. ERBB2 drives YAP activation and EMT-like processes during cardiac regeneration Alla Aharonov1, Avraham Shakked1, Kfir Baruch Umansky1, Alon Savidor2 , David Kain1, Daria Lendengolts1, Or-Yam Revach1, Yuka Morikawa3, Jixin Dong4, Yishai Levin2, Benjamin Geiger1, James F. Martin5 and Eldad Tzahor*1 1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 7610001, Israel. 2The De Botton Protein Profiling institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, 7610001, Israel. 3The Texas Heart Institute Cardiomyocyte Renewal Lab, Houston, Texas, 77030, USA. 4 Eppley Institute for Research in Cancer, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha 68198, NE, USA. 5 Department of Molecular Physiology and Biophysics, Baylor College of Medicine, and The Texas Heart Institute Cardiomyocyte Renewal Lab, Houston, Texas, 77030, USA. *Correspondence:
[email protected] Summary Cardiomyocyte (CM) loss after injury results in adverse remodelling and fibrosis, which inevitably lead to heart failure. ERBB2-Neuregulin and Hippo-YAP signaling pathways are key mediators of CM proliferation and regeneration, yet the crosstalk between these pathways is unclear. Here, we demonstrate in adult mice that transient over-expression (OE) of activated ERBB2 in CMs promotes cardiac regeneration in a heart failure model.